Barton Debora 4
4 · TScan Therapeutics, Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Barton Debora
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-07-05+150,000→ 150,000 totalExercise: $3.17Exp: 2032-07-04→ Voting Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following July 5, 2022, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer.